TEM is a data-rich platform that recently clinched a $200 million deal with AstraZeneca. TEM’s main bet is now on AI for ...

人工智能医疗公司Tempus AI (TEM) 的股价从上周 11.8% 的跌幅中反弹，在 6 月份迎来了良好的开局。除了上周末该公司发布了两份公告外，投资者还对 TD Cowen 就 Spruce Point ...

Tempus AI is developing innovative AI solutions for the treatment of cancer and other diseases. Shares of Tempus AI plummeted ...

The IPO market remains frozen in 2025, keeping startups like Kin and M1 in limbo. Here’s why deals are stalled—and what that ...

Tempus AI extended its winning streak to a third consecutive day on Monday, jumping 15.02 percent to close at $63.47 apiece ...

Shares of Tempus AI ( TEM 14.71%) soared on Monday. The company's stock jumped 15% as of market close. The spike comes as the ...

Tempus AI Inc. (NASDAQ:TEM) announced the expansion of its GenAI clinical assistant, called Tempus One, with direct ...

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Tempus AI, Inc. (NASDAQ: TEM) resulting from allegations ...

The company stated that the assay, currently available for research use, will be clinically available later this year.

Tempus AI Inc (NASDAQ:TEM) shares are moving higher Monday after the company introduced a new program to monitor ...

E.L.F. Beauty’s stock is up more than 34% in the last week. The positive performance, primarily driven by an over 23% surge ...

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Tempus AI, Inc. resulting from allegations that Tempus AI ...